Last reviewed · How we verify

NCT04125199: (EDA)

Effects of Decohexaenoic Acid Supplementation on Markers of Inflammatory Muscle Damage

Completed NA Last updated 17 October 2019
What this trial tests

NA trial testing supplement consumption in Sport in 15 participants. Completed in 22 December 2016.

Timeline
1 January 2016
Primary endpoint
22 December 2016
22 December 2016

Quick facts

Lead sponsorUniversidad Católica San Antonio de Murcia
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingquadruple
Primary purposeprevention
Enrollment15
Start date1 January 2016
Primary completion22 December 2016
Estimated completion22 December 2016
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Universidad Católica San Antonio de Murcia

Who can join

Adults 18 to 45, male only, with Sport. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Randomized, placebo-controlled, double-blind, placebo-controlled clinical trial consisting of 15 triathletes in which it is intended to observe less inflammatory damage at the muscular level after performing eccentric exercises.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Supplementation of Re-Esterified Docosahexaenoic and Eicosapentaenoic Acids Reduce Inflammatory and Muscle Damage Markers after Exercise in Endurance Athletes: A Randomized, Controlled Crossover Trial.
    Ramos-Campo DJ, Ávila-Gandía V, López-Román FJ, Miñarro J, et al · · 2020 · cited 23× · PMID 32182747 · DOI 10.3390/nu12030719

Verify or expand the search:

Other recruiting trials for Sport

Currently open trials in the same condition.

Other Universidad Católica San Antonio de Murcia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04125199.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing